Clinical application of a selenium (75Se)-labelled bile acid for the investigation of terminal ileal function
- PMID: 6479839
Clinical application of a selenium (75Se)-labelled bile acid for the investigation of terminal ileal function
Abstract
With the introduction of a selenium bile acid SeHCAT (tauro-23-75Se-Selena-25 homocholic acid) a new and clinically valuable test for the functioning of the terminal ileum has been made available. Previous studies have shown that the test detects patients with bile acid malabsorption due to ileal disease. In this study SeHCAT retention was evaluated in nine patients with Crohn's disease and in seven healthy controls after intravenous administration of 0.15 MBq (4 muCi). A simple way of expressing the results is proposed. By using the calculated time required to eliminate 50% of the SeHCAT (WBR50), information is obtained as to the degree of terminal ileum malfunction regarding bile acid absorption. Accurate values seem to be achieved within 48 hours. As the SeHCAT is a gamma-ray emitter the dose retained could be measured by external counting. We suggest a practical design for the test using a simple scintillation spectro-photometer with a single detector in a low-background room. In patients and healthy controls the SeHCAT retention as calculated by WBR50 was 63 hrs (15-163) and 120 hrs (range 99-141), respectively. There was no overall relation between SeHCAT elimination and the intestinal transit time, although in the patient group a significant correlation was demonstrated, probably secondary to the impairment of the terminal ileum. A significant correlation was shown between the outcome of the test and the faecal excretion of total bile acids.
Similar articles
-
Absence of histopathological changes of ileum and colon in functional chronic diarrhea associated with bile acid malabsorption, assessed by SeHCAT test: a prospective study.Am J Gastroenterol. 1994 Jul;89(7):1058-61. Am J Gastroenterol. 1994. PMID: 8017365
-
Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms.Scand J Gastroenterol. 2011 Jul;46(7-8):818-22. doi: 10.3109/00365521.2011.574728. Epub 2011 Apr 15. Scand J Gastroenterol. 2011. PMID: 21492055
-
Plasma lathosterol as a screening test for bile acid malabsorption due to ileal resection: correlation with 75SeHCAT test and faecal bile acid excretion.Clin Sci (Lond). 1996 Apr;90(4):315-9. doi: 10.1042/cs0900315. Clin Sci (Lond). 1996. PMID: 8777839
-
Detection of bile acid malabsorption by the SeHCAT test.Gastroenterol Clin Biol. 1994;18(10):847-51. Gastroenterol Clin Biol. 1994. PMID: 7875392 Review. No abstract available.
-
[The clinical importance of physiopathological studies of the bile salts performed using the gamma-emitting bile acid SeHCAT].Minerva Gastroenterol Dietol. 1992 Oct-Dec;38(4):197-206. Minerva Gastroenterol Dietol. 1992. PMID: 1296778 Review. Italian.
Cited by
-
The bile acid turnover rate assessed with the (75)SeHCAT test is stable in chronic diarrhoea but slightly decreased in healthy subjects after a long period of time.Dig Dis Sci. 2008 Nov;53(11):2935-40. doi: 10.1007/s10620-008-0256-4. Epub 2008 Apr 25. Dig Dis Sci. 2008. PMID: 18437571
-
Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology.Gut. 1991 Oct;32(10):1180-7. doi: 10.1136/gut.32.10.1180. Gut. 1991. PMID: 1955174 Free PMC article.
-
Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT.Gut. 1994 Jan;35(1):90-3. doi: 10.1136/gut.35.1.90. Gut. 1994. PMID: 8307458 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials